Joseph A. Moore, M.D. Curriculum Vitae—Page 1

CURRICULUM VITAE

JOSEPH A. MOORE, M.D.

PRESENT TITLE: Hematology & Oncology Staff Physician Cancer Center of Kansas

OFFICE ADDRESS: 3243 E Murdock, Ste 300 Wichita, KS 67208

OFFICE PHONE: (316) 262-4467 / Fax: (316) 262-0706

EDUCATION Chief Oncology Fellow, Hematology and Oncology Fellowship 6/2020 – 6/2021 The University of Texas MD Anderson Cancer Center, Houston, TX Fellowship 7/2018 – 6/2021 The University of Texas MD Anderson Cancer Center, Houston, TX Hematology and Oncology Fellowship Postgraduate 7/2015 – 6/2018 University of Texas Southwestern Medical Center, Dallas, TX Internal Medicine Residency Graduate 8/2011 – 5/2015 University of Kansas School of Medicine (KUMC), Kansas City, KS Doctor of Medicine (AOA) Undergraduate 8/2007 – 5/2011 University of Kansas (KU), Lawrence, KS Bachelor of Arts in Human Biology (Highest Distinction)

LICENSURE/CERTIFICATION American Board of Internal Medicine – Pass, August 2018 (ID 388181) Medical Licensure—State of Kansas, 2021 Medical Licensure—State of Texas, 2016 USMLE Step 3 – Pass (257), October 2015 USMLE Step 2 CS – Pass, August 2014 USMLE Step 2 CK – Pass (272), July 2014 USMLE Step 1 – Pass (252), May 2013

EXPERIENCE/SERVICE Member, Acute & Critical Care Subcommittee, The University of Texas 2019 - 2020 MD Anderson Cancer Center, Houston, TX

Code Blue Chair, The University of Texas MD Anderson Cancer Center, 2019 - 2020 Houston, TX

Clinical Specialist, Department of Critical Care and Respiratory Care, 2018 - 2021 Division of Anesthesiology, Critical Care and Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Joseph A. Moore, M.D. Curriculum Vitae—Page 2

HONORS & AWARDS Mahlon H. Delp Student Award in Internal Medicine 2015 P.G. Czarlinsky Family Award for Excellence 2015 KUMC Neurology Clerkship Top Achiever Award 2015 Alpha Omega Alpha Honor Medical Society 2014 Clerkship Honors—Surgery, Internal Medicine, Family Medicine, 2013-2014 Psychiatry, Neurology, Geriatrics, Pediatrics, OBGYN NIH Endowment Diversity Scholarship Award 2011-2015 KUMC Graduate Studies Summer Scholarship Award 2012 Graduated with Highest Distinction from KU 2011 Mortar Board Senior Honor Society 2011 Phi Kappa Phi Emerging Scholar Award 2008 KU Department of Chemistry Book Award 2008 KU Summerfield Scholar 2007-2011 Eagle Scout, Boy Scouts of America 2007

RESEARCH EXPERIENCE Grants (not funded) “Clinical Application of Novel, Specific MicroRNA Biomarkers for the Management of Germ Cell Tumors of the Testis” submitted for 2020 Conquer Cancer Foundation Young Investigator Award

PUBLICATIONS Umbreit EC, Siddiqui BA, Hwang MJ, Joon AY, Maity T, Westerman ME, Merriman KW, Alhasson H, Uthup J, Guo T, Moore JA, Ward JF, Karam JA, Wood CG, Pisters LL, Zhang M, Tu SM. Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell Tumor. Cancers: 12(12):3755, 2020.

Chertack N, Ghandour RA, Singla N, Freifeld Y, Hutchinson R, Courtney K, Moore JA, Aydin AA, Margulis V, Lotan Y, Woldu S, Bagrodia A. Overcoming Sociodemographic Factors in the Care of Testicular Cancer Patients at a Safety Net Hospital. Cancer: 126(19):4362-4370, 2020.

Moore JA, Hubbi ME, Wang C, Wang Y, Luo W, Hofmann S, Rambally S. Isolated Erythrocytosis Associated with Three Novel Missense Mutations in the EGLN1 Gene. J Investig Med High Impact Case Rep: 8:1-4, 2020.

Jaoude DA, Moore JA, Moore MB, Twumasi-Ankrah P, Ablah E, Moore DF Jr. Glioblastoma and Increased Survival with Longer Chemotherapy Duration. Kans J Med: 12(3):65-69, 2019.

Woldu SL*, Moore JA*, Chi B, Freifeld Y, Clinton T, Aydin AM, Singla N, Krabbe LM, Hutchinson RC, Amatruda JF, Sagalowsky A, Lotan Y, Arriaga Y, Margulis V, Xie Y, Bagrodia A. Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes. Eur Urol Oncol: 1(3):242-251, 2018. (*denotes co-first author)

Gupta A, Moore JA. Tumor Lysis Syndrome. JAMA Oncol: 4(6):895, 2018.

Gupta A, Moore JA. Lymphedema. JAMA Oncol: 4(5): 766, 2018. Joseph A. Moore, M.D. Curriculum Vitae—Page 3

Woldu SL, Bagrodia A, Moore JA, Arriaga Y. Reply to “Challenges in the Care of Hispanic Men with Testicular Germ Cell Tumor”. Urology: 2017.

Hendren N, Moore JA, Hofmann SL, Rambally S. Resolution of Acute Hepatitis B- associated Aplastic Anemia with Antiviral Therapy. BMJ Case Rep: 2017.

Moore JA, Gliga L, Nagalla S. Thyroid Storm & Warm Autoimmune Hemolytic Anemia. Transfus Apher Sci: 56(4):606-608, 2017.

Moore JA, Rambally S. Fusobacterium nucleatum Bacteremia Presenting with Portal Vein Thrombosis: An Abdominal Lemierre Syndrome? Am J Med: 130(6):e255-256, 2017.

Moore JA, Moore MB, Samaniego F, Pinnix CC, Moore DF Jr. Small Lymphocytic Lymphoma Presenting with Hypopituitarism. Am J Med: 129(1):e9-e10, 2016.

Complete List of Published Work in My Bibliography: https://www.ncbi.nlm.nih.gov/myncbi/10ebdpuvxdmQip/bibliography/public/ ORCiD: https://orcid.org/0000-0002-8127-9060

ABSTRACTS Chertack N, Ghandour RA, Singla N, Freifeld Y, Hutchinson R, Courtney K, Moore JA, Aydin AA, Margulis V, Lotan Y, Woldu S, Bagrodia A. Overcoming Sociodemographic Factors in the Care of Testicular Cancer Patients at a Safety Net Hospital. Published for 2020 Annual Meeting of the Genitourinary Cancers Symposium, February 14, 2020, San Francisco, CA.

Woldu SL, Moore JA, Friefeld Y, Clinton T, Singla N, Krabbe LM, Hutchinson R, Lotan Y, Arriaga YE, Margulis V, Bagrodia A. Utilization and Impact of Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Advanced Non-Seminomatous Germ Cell Tumor. Published for 2018 Annual Meeting of the American Urologic Association, May 18, 2018, San Francisco, CA.

Choi SH, Moore JA, Luo X, Xie Y, Arriaga YE. A Retrospective Case Control Study to Identify Differences in Risk Factors for the Development of Renal Cell Carcinoma in Patients Treated at a Safety Net Hospital Compared to Patients Treated at a Private Hospital [Abstract e16122]. Published for 2016 Annual Meeting of The American Society of Clinical Oncology, June 3, 2016, Chicago, IL.

Choi SH, Moore JA, Luo X, Xie Y, Arriaga YE. Comparing Outcomes of Renal Cell Carcinoma Diagnostic and Treatment Intervals within Two Different Hospital Systems in a Single Academic Medical Center [Abstract e16093]. Published for 2016 Annual Meeting of The American Society of Clinical Oncology, June 3, 2016, Chicago, IL.

Moore JA, Moore MB, Samaniego F, Pinnix CC, Moore DF. Small Lymphocytic Lymphoma Presenting with Hypopituitarism. Abstract published for 2015 National Internal Medicine Meeting of the American College of Physicians, May 2, 2015, Boston, MA.

Abou-Jaoude D, Moore JA, Moore MB, Twumasi-Ankrah P, Ablah E, Moore DF. Glioblastoma and Increased Survival with Longer Chemotherapy Duration [Abstract Joseph A. Moore, M.D. Curriculum Vitae—Page 4

e13006]. Published for 2013 Annual Meeting of The American Society of Clinical Oncology, May 31, 2013, Chicago, IL.

BOOK CHAPTERS Moore JA and Tu SM, Germ Cell Tumors, In: The MD Anderson Manual of Medical Oncology, 4th edition, McGraw Hill, xxx-xxx, 2021.

REGIONAL / NATIONAL PRESENTATIONS Moore JA, Woldu SL, Friefeld Y, Clinton T, Singla N, Krabbe LM, Hutchinson R, Lotan Y, Arriaga YE, Margulis V, Bagrodia A. “Utilization and Impact of Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Advanced Non-Seminomatous Germ Cell Tumor.” Presented at UT Southwestern Donald W. Seldin Research Symposium, May 3, 2018, Dallas, TX.

Moore JA, Gliga L, Nagalla S. “Thyroid Storm & Warm Autoimmune Hemolytic Anemia.” Presented at American College of Physicians Northeast Texas Associates Day, May 16, 2017, Dallas, TX. Also presented at UT Southwestern Donald W. Seldin Research Symposium, May 4, 2017, Dallas, TX.

Moore JA, Hendren N, Hofmann SL, Rambally S. “HBV-Induced Pancytopenia: Aplastic Anemia or Mimic?”. Presented at UT Southwestern Donald W. Seldin Research Symposium, May 4, 2017, Dallas, TX.

Moore JA, Moore MB, Samaniego F, Pinnix CC, Moore DF. “Small Lymphocytic Lymphoma Presenting with Hypopituitarism.” Presented at American College of Physicians National Meeting, May 2, 2015, Boston, MA. Also presented at University of Kansas School of Medicine Annual Research Forum, April 29, 2015, Wichita, KS.

LOCAL PRESENTATIONS Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. Presented at MDACC Hong’s Journal Club, May 12, 2020, Houston, TX.

Approach to Isolated Erythrocytosis. Presented at MDACC Hong’s Hematology Case Conference, June 18, 2019, Houston, TX.

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer. Presented at MDACC Breast Medical Oncology Journal Club, April 24, 2019, Houston, TX.

Prolyl Hydroxylase Domain Mutant Erythrocytosis. Presented at Memorial Herman Hematology Case Conference, March 19, 2019, Houston, TX.

Acute Lymphoblastic Leukemia in Jehovah’s Witnesses: A Challenge for Hematologists. Presented at Houston Citywide Hematology Conference, March 06, 2019, Houston, TX.

Integrated Molecular Characterization of Testicular Germ Cell Tumors. Presented at MDACC Genitourinary Medical Oncology Journal Club, February 22, 2019, Houston, TX.

Joseph A. Moore, M.D. Curriculum Vitae—Page 5

Neoadjuvant versus Adjuvant Ipilimumab Plus Nivolumab in Macroscopic Stage III Melanoma. Presented at MDACC Melanoma Medical Oncology Journal Club, November 26, 2018, Houston, TX.

Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma. Presented at MDACC Gastrointestinal Medical Oncology Journal Club, October 17, 2018, Houston, TX.

Oncologist Volume and Outcomes in Older Adults Diagnosed with Diffuse Large B Cell Lymphoma. Presented at MDACC Lymphoma Myeloma Journal Club, September 25, 2018, Houston, TX.

Improving Long-Term Outcomes for Patients with Extra-Abdominal Soft Tissue Sarcoma Regionalization to High-Volume Centers, Improved Compliance with Guidelines or Both?. Presented at MDACC Sarcoma Medical Oncology Journal Club, August 13, 2018, Houston, TX.

Pembrolizumab Plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. Presented at MDACC Thoracic Head & Neck Medical Oncology Journal Club, July 26, 2018, Houston, TX.

The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. Presented at UTSW Internal Medicine Journal Club, March 19, 2018, Dallas, TX.

TEACHING EXPERIENCE Undergraduate Teaching Assistant, Introductory Biology Lab 8/2009 – 5/2011 University of Kansas, Course Organizer: Dr. Julie Campbell

EXTRACURRICULAR ACTIVITIES KUMC Internal Medicine Student Interest Group 2012-2015 Jaydoc Free Healthcare Clinic, Volunteer 2009-2015 KUMC Medical Student Assembly, Representative 2012-2013 KUMC Student Governing Council, Senator 2012-2013 KUMC Faculty Council, Student Representative 2012-2013 Senior Advisory Board, KU Board of Class Officers 2010-2011 President, Pi Deuteron Chapter of Phi Gamma Delta 2009-2011

PROFESSIONAL MEMBERSHIPS American Society for Transplantation and Cellular Therapy 2020 – Present American Society of Hematology 2018 – Present American Society of Clinical Oncology 2016 – Present Alpha Omega Alpha 2014 – Present American Medical Association 2011 – Present American College of Physicians 2011 – Present

UPDATED: 7/1/21